Exploring the Potential of s-Triazine Derivatives as Novel Antifungal Agents: A Review
Pharmaceuticals · 07.05.2025 · 18 (5) · 690
DOI: 10.3390/ph18050690 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.05.2025. Verfasst von Haoyan Liao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Bridge, College of Basic Medical Sciences, Naval Medical University, No. 800 Xiangyin Road, Shanghai 200433, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Naval Key Discipline Professional Project, Naval Medical University Young Research Fellowship Grant.
Abstract (Originalsprache)
The growing incidence and prevalence of invasive fungal infections (IFIs) and the emergence of antimicrobial resistance compound clinical antifungal therapies. Given the significant threat posed by IFIs and the limits of the current antifungal agents, the search for novel, effective therapeutic options remains a compelling area of antifungal drug discovery. The s-triazine (1,3,5-triazine) scaffold, renowned for its structural versatility, ease of functionalization, and diverse biological profiles, has been extensively studied in medical chemistry. Driven by this privileged structure, several s-triazine derivatives have been synthesized through molecular hybridization and screened for their antifungal activities. Some of them demonstrated potent efficacy against pathogenic fungi, including Candida, Cryptococcus, and Aspergillus species. Structure–activity relationship (SAR) studies are also discussed whenever possible, underlying the essential substituents for their antifungal effect. This review provides a summary of recent advancements (2014–2024) in the development of antifungal agents featuring the s-triazine scaffold and highlights the antifungal activity of s-triazine derivatives, aiming to prompt further progress in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Bridge, College of Basic Medical Sciences, Naval Medical University, No. 800 Xiangyin Road, Shanghai 200433, China.
- Department of Organic Chemistry, School of Pharmacy, Naval Medical University, No. 325 Guohe Road, Shanghai 200433, China.
ORCID-Profile: Fei Xie
Förderung
- National Natural Science Foundation of China
- Naval Key Discipline Professional Project
- Naval Medical University Young Research Fellowship Grant
- Naval Medical University Undergraduates' Innovation and Practice Training Programs
- Naval Medical University Undergraduates’ Innovation and Practice Training Programs
Zitieren
APA
Liao, H., Liu, M., Wang, M., Zhang, D., Hao, Y., & Xie, F. (2025). Exploring the Potential of s-Triazine Derivatives as Novel Antifungal Agents: A Review. Pharmaceuticals, 18(5), 690. https://doi.org/10.3390/ph18050690
Vancouver
Liao H, Liu M, Wang M, Zhang D, Hao Y, Xie F. Exploring the Potential of s-Triazine Derivatives as Novel Antifungal Agents: A Review. Pharmaceuticals. 2025;18(5):690. doi:10.3390/ph18050690
BibTeX
@article{Liao2025,
author = {Liao, Haoyan and Liu, Menglu and Wang, Mengyuan and Zhang, Dazhi and Hao, Yumeng and Xie, Fei},
title = {Exploring the Potential of s-Triazine Derivatives as Novel Antifungal Agents: A Review},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {5},
pages = {690},
doi = {10.3390/ph18050690}
}
EUVIMED